Consumers are becoming more aware that keeping the mouth and teeth clean is a key component of a healthy lifestyle. Overall, sales of oral care products at multi-outlets rose by 2% or more for the 52-week period ended July 20, according to IRI.
Bayer Consumer’s Dr Scholl’s, which generated $291.9 million in sales for the 52 weeks ended June 4, according to Nielsen data as provided by Implus, still dominates the foot care category, while store brands gained 7.4% in that time frame to $65.6 million, and Implus gained 47.5% with the Airplus brand to $40.7 million.
Quest Products is looking to break onto the external analgesic scene with CopperFixx, a balm that combines the analgesic properties associated with copper and arnica. Other brands continuing to lead the way were Blue Emu ($28.6 million, up 20.1%), Australian Dream ($23.1 million, up 20.7%) and Boiron’s Arincare ($19.1 million, up 19.7%).
Pfizer’s Nexium 24HR is the clear leader in the digestive aisle. However, in March 2017, store-brand versions of Nexium 24HR will be available. Perrigo has already secured a tentative approval from the Food and Drug Administration for its OTC Nexium 24HR generic equivalent.